Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR
Jin Yong Kim
Abstract
1/4 https://jkms.org I am grateful that Dr. Lim and his colleagues reported a case of COVID-19 that caused tertiary transmission in Korea and added information about the novel infectious disease. 1 In this report, the authors emphasized the decrease in viral titer due to the effects of antiviral administration. However, I would like to discuss what to look out for when interpreting the causal relationship between laboratory results and therapeutic effects.
Topics & Concepts
LopinavirMedicineRitonavirLopinavir/ritonavirCoronavirus disease 2019 (COVID-19)Transmission (telecommunications)Viral pneumoniaTiterPneumoniaVirologyAntiviral drugInternal medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseViral loadVirusImmunologyInfectious disease (medical specialty)Antiretroviral therapyEngineeringElectrical engineeringCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing